Record Details

Lung Screening, Tobacco, and Health (LSTH) Trial data

Harvard Dataverse (Africa Rice Center, Bioversity International, CCAFS, CIAT, IFPRI, IRRI and WorldFish)

View Archive Info
 
 
Field Value
 
Title Lung Screening, Tobacco, and Health (LSTH) Trial data
 
Identifier https://doi.org/10.7910/DVN/0O31JY
 
Creator Taylor, Kathryn
 
Publisher Harvard Dataverse
 
Description

ABSTRACT


Background. Lung cancer mortality is reduced via low-dose CT screening and treatment of early-stage disease. Evidence-based smoking cessation treatment in the lung screening setting can further reduce mortality. We report the results of a cessation trial from the NCI’s SCALE collaboration.


Methods. Eligible patients (N=818) aged 50-80 were randomized (May 2017-January 2021) to the Intensive vs. Minimal arms (8 vs. 3 phone sessions plus 8 vs. 2 weeks of nicotine patches, respectively). Bio-verified (primary) and self-reported 7-day abstinence rates were assessed 3-, 6-, and 12-months post-randomization. Logistic regression analyses evaluated the effects of study arm. All statistical tests were two-sided.


Results. Participants reported 48.0 (SD=17.2) pack-years and 51.6% were not ready to quit in

 
Subject Medicine, Health and Life Sciences
Social Sciences
Early Detection of Cancer, Lung / diagnostic imaging, Lung Neoplasms / diagnosis, Lung Neoplasms / diagnostic imaging, Randomized Controlled Trials as Topic, Smoking Cessation / methods, Telephone, Tomography, X-Ray Computed, Middle Aged, humans, cancer,
 
Language English
 
Contributor Taylor, Kathryn